Low Wang, C.C.; Chong, T.; Moore, G.; Echalier, B.; Haakonsen, N.; Carter, J.E., Jr.; Mathes, D.; Hsia, J.; Phan, T.T.; Lim, I.J.;
et al. Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers. Biomedicines 2024, 12, 1375.
https://doi.org/10.3390/biomedicines12061375
AMA Style
Low Wang CC, Chong T, Moore G, Echalier B, Haakonsen N, Carter JE Jr., Mathes D, Hsia J, Phan TT, Lim IJ,
et al. Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers. Biomedicines. 2024; 12(6):1375.
https://doi.org/10.3390/biomedicines12061375
Chicago/Turabian Style
Low Wang, Cecilia C., Tae Chong, Garrett Moore, Benjamin Echalier, Nicola Haakonsen, James E. Carter, Jr., David Mathes, Judith Hsia, Toan Thang Phan, Ivor J. Lim,
and et al. 2024. "Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers" Biomedicines 12, no. 6: 1375.
https://doi.org/10.3390/biomedicines12061375
APA Style
Low Wang, C. C., Chong, T., Moore, G., Echalier, B., Haakonsen, N., Carter, J. E., Jr., Mathes, D., Hsia, J., Phan, T. T., Lim, I. J., & Freed, B. M.
(2024). Results of the Phase 1 Open-Label Safety Study of Umbilical Cord Lining Mesenchymal Stromal/Stem Cells (Corlicyte®) to Heal Chronic Diabetic Foot Ulcers. Biomedicines, 12(6), 1375.
https://doi.org/10.3390/biomedicines12061375
